Liu Z - Search Results

1

Identification of small-molecule inhibitors against human leukocyte antigen-death receptor 4 (HLA-DR4) through a comprehensive strategy.

Liu Z, Li B, Li X, Zhang L, Lai L. Liu Z, et al. J Chem Inf Model. 2011 Feb 28;51(2):326-34. doi: 10.1021/ci100444c. Epub 2011 Feb 2. J Chem Inf Model. 2011. PMID: 21284404

2

[Modeling of the SARS coronavirus main proteinase and conformational flexibility of the active site].

Liu S, Pei J, Chen H, Zhu X, Liu Z, Ma W, He F, Lai L. Liu S, et al. Among authors: liu z. Beijing Da Xue Xue Bao Yi Xue Ban. 2003 May 31;35 Suppl:62-5. Beijing Da Xue Xue Bao Yi Xue Ban. 2003. PMID: 12914221 Chinese.

3

Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase.

Liu Z, Huang C, Fan K, Wei P, Chen H, Liu S, Pei J, Shi L, Li B, Yang K, Liu Y, Lai L. Liu Z, et al. Among authors: liu y, liu s. J Chem Inf Model. 2005 Jan-Feb;45(1):10-17. doi: 10.1021/ci049809b. J Chem Inf Model. 2005. PMID: 15667124

4

3D-QSAR studies on tripeptide aldehyde inhibitors of proteasome using CoMFA and CoMSIA methods.

Zhu YQ, Pei JF, Liu ZM, Lai LH, Cui JR, Li RT. Zhu YQ, et al. Bioorg Med Chem. 2006 Mar 1;14(5):1483-96. doi: 10.1016/j.bmc.2005.10.003. Epub 2005 Oct 26. Bioorg Med Chem. 2006. PMID: 16256351

5

Improving the quality of 3D-QSAR by using flexible-ligand receptor models.

Pei J, Chen H, Liu Z, Han X, Wang Q, Shen B, Zhou J, Lai L. Pei J, et al. Among authors: liu z. J Chem Inf Model. 2005 Nov-Dec;45(6):1920-33. doi: 10.1021/ci050203c. J Chem Inf Model. 2005. PMID: 16309299

6

PSI-DOCK: towards highly efficient and accurate flexible ligand docking.

Pei J, Wang Q, Liu Z, Li Q, Yang K, Lai L. Pei J, et al. Among authors: liu z. Proteins. 2006 Mar 1;62(4):934-46. doi: 10.1002/prot.20790. Proteins. 2006. PMID: 16395666

7

Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.

Lai L, Han X, Chen H, Wei P, Huang C, Liu S, Fan K, Zhou L, Liu Z, Pei J, Liu Y. Lai L, et al. Among authors: liu z, liu y, liu s. Curr Pharm Des. 2006;12(35):4555-64. doi: 10.2174/138161206779010396. Curr Pharm Des. 2006. PMID: 17168761 Review.

8

Three-dimensional structure of HIV-1 VIF constructed by comparative modeling and the function characterization analyzed by molecular dynamics simulation.

Lv W, Liu Z, Jin H, Yu X, Zhang L, Zhang L. Lv W, et al. Among authors: liu z. Org Biomol Chem. 2007 Feb 21;5(4):617-26. doi: 10.1039/b612050d. Epub 2007 Jan 18. Org Biomol Chem. 2007. PMID: 17285170

9

Novel 8-deaza-5,6,7,8-tetrahydroaminopterin derivatives as dihydrofolate inhibitor: design, synthesis and antifolate activity.

Zhang Z, Wu J, Ran F, Guo Y, Tian R, Zhou S, Wang X, Liu Z, Zhang L, Cui J, Liu J. Zhang Z, et al. Among authors: liu z, liu j. Eur J Med Chem. 2009 Feb;44(2):764-71. doi: 10.1016/j.ejmech.2008.04.017. Epub 2008 May 4. Eur J Med Chem. 2009. PMID: 18555562

10

N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer.

Wang YM, Hu LX, Liu ZM, You XF, Zhang SH, Qu JR, Li ZR, Li Y, Kong WJ, He HW, Shao RG, Zhang LR, Peng ZG, Boykin DW, Jiang JD. Wang YM, et al. Clin Cancer Res. 2008 Oct 1;14(19):6218-27. doi: 10.1158/1078-0432.CCR-08-0550. Clin Cancer Res. 2008. PMID: 18829501

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91,001 results

Search Page

Filters